
Bioregulators
Pinealon
Pinealon is a synthetic tripeptide with the sequence Glu-Asp-Arg (EDR). It is one of the short 'bioregulator' peptides studied mainly by the St. Petersburg Institute of Bioregulation and Gerontology group.
- Container
- Glass vial, crimp seal, flip-top cap
- Storage
- -20 °C, desiccated
- Paperwork
- Lot certificate (HPLC + mass spec) shown before you pay
Lot certificates
You’ll see American Peptides on the lab’s copy. They’re our supplier.
- 20 mg, lot PINE20-0803: 99.68% purity (RP-HPLC), 20.80 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7610
Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.
What researchers study it for
- Oxidative stress in cultured neurons
- Prenatal hyperhomocysteinemia in rats
- Alzheimer's disease cell models
- Peptide binding to DNA and histones
How it is thought to work
The mechanism is not established. Cell studies report lower accumulation of reactive oxygen species, less necrotic cell death and delayed ERK 1/2 activation. A 2020 review by the same group proposes that the peptide enters cells and binds histones or nucleic acids, changing gene expression; the review words this as an assumption.
Where the research stands
Mainly preclinical; small Russian human studies. Most published work is in cells and rats and comes from one research group. Human reports are small and appear mainly in Russian-language journals. No trials were found on ClinicalTrials.gov and no FDA-approved product was found.
Sources
- Khavinson V, et al. (2011). Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Research.
- Arutjunyan A, et al. (2012). Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. International Journal of Clinical and Experimental Medicine.
- Khavinson V, et al. (2020). EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease. Molecules.
- Meshchaninov VN, et al. (2015). [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION]. Advances in Gerontology (Uspekhi Gerontologii).
Read more
For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.
